Pharmaceuticals Global On demand · 24-48h

Global Butylphthalide API Market Strategic Research Report

Global Butylphthalide API Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Butylphthalide API Market
$22.62025
9.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: dl-NBP, l-NBP

By Application: Acute Ischemic Stroke (AIS), Neurodegenerative Diseases, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: CSPC Pharmaceutical, Hebei Guangxiang Pharmaceutical, Fujian South Pharmaceutical, Xiangbei Welman Pharmaceutical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 77 pages
Market size 2025
$22.6
Million USD
Forecast CAGR
9.5%
2025-2032
Forecast 2032
$42.7
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Butylphthalide API market size is predicted to grow from US$ 22.60 million in 2025 to US$ 41.92 million in 2032; it is expected to grow at a CAGR of 9.5% from 2026 to 2032.

In 2025, global Butylphthalide API production reached approximately 33 tons, with an average global market price of around US$700 per kilogram. Butylphthalide (specifically 3-n-butylphthalide or NBP, CAS 6066-49-5) is a neuroprotective Active Pharmaceutical Ingredient (API) derived from celery seed, primarily used to treat acute ischemic stroke. It improves cerebral blood flow, acts as an antioxidant, and protects the blood-brain barrier.

Based on our research,Butylphthalide API is not a broad commodity API market; it is a specialty API segment built around a single high-value originator molecule, formulation patent boundaries, regulatory filings, and the pace of generic or modified formulation entry. For many years, the API supply was largely integrated into the originator’s formulation system, and the external merchant market remained limited. As more Chinese manufacturers obtain production licenses, registration numbers, or approval notices for butylphthalide API, the industry is moving from a captive-supply model toward a structure led by the originator and supplemented by emerging specialty API producers. Since the downstream butylphthalide formulation market is still heavily centered in China’s clinical and reimbursement system, the global API supply base is also highly concentrated in China; overseas names identified in public searches are mostly reagent suppliers, sourcing agents, or unverified leads rather than confirmed drug-grade commercial API manufacturers.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Butylphthalide API market?

What factors are driving Butylphthalide API market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Butylphthalide API market opportunities vary by end market size?

How does Butylphthalide API break out by Type, by Application?

This report presents a comprehensive overview of the global Butylphthalide API market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • dl-NBP
  • l-NBP

Segment by Purity

  • Purity ≥99%
  • Purity ≥99.5%

Segment by Dosage Form

  • Capsule
  • Injection

Segment by Application

  • Acute Ischemic Stroke (AIS)
  • Neurodegenerative Diseases
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Butylphthalide API market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Acute Ischemic Stroke (AIS), Neurodegenerative Diseases, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Butylphthalide API Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 9.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$22.6
2025
Forecast
$42.7
2032
CAGR
9.5%
2025–2032
Regions
5
global
Key companies
CSPC PharmaceuticalHebei Guangxiang PharmaceuticalFujian South PharmaceuticalXiangbei Welman Pharmaceutical
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
dl-NBPl-NBP
By Application
Acute Ischemic Stroke (AIS)Neurodegenerative DiseasesOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 dl-NBP
  • 3.1.3 l-NBP
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Acute Ischemic Stroke (AIS)
  • 4.1.3 Neurodegenerative Diseases
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 CSPC Pharmaceutical
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Hebei Guangxiang Pharmaceutical
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Fujian South Pharmaceutical
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Xiangbei Welman Pharmaceutical
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Butylphthalide API market?
The global Butylphthalide API market is estimated at US$ 22.6 million in 2025 (base year) and is projected to reach US$ 41.92 million by 2032.
What is the forecast CAGR for the Butylphthalide API market?
The market is expected to grow at a CAGR of 9.5% from 2026 to 2032, expanding from US$ 22.6 million in 2025 to US$ 41.92 million in 2032, roughly 1.9 times its base-year value.
What is Butylphthalide API?
In 2025, global Butylphthalide API production reached approximately 33 tons, with an average global market price of around US$700 per kilogram. Butylphthalide (specifically 3-n-butylphthalide or NBP, CAS 6066-49-5) is a neuroprotective Active Pharmaceutical Ingredient (API) derived from celery seed, primarily used to treat acute ischemic stroke. It improves cerebral blood flow, acts as an antioxidant, and protects the blood-brain barrier.
How is the Butylphthalide API market segmented by type?
By type, the market is segmented into dl-NBP and l-NBP.
What are the key applications of Butylphthalide API?
Key applications covered include Acute Ischemic Stroke (AIS), Neurodegenerative Diseases and Others.
Which companies are profiled in the Butylphthalide API market report?
Key players profiled include CSPC Pharmaceutical, Hebei Guangxiang Pharmaceutical, Fujian South Pharmaceutical and Xiangbei Welman Pharmaceutical.
What geographies does the Butylphthalide API market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Butylphthalide API?
What factors are driving Butylphthalide API market growth, globally and by region?
What are the main risks and barriers in the Butylphthalide API market?
It improves cerebral blood flow, acts as an antioxidant, and protects the blood-brain barrier.
Who should buy the Butylphthalide API market report?
The report is intended for manufacturers and solution providers, distributors and end users in Acute Ischemic Stroke (AIS), Neurodegenerative Diseases and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Butylphthalide API market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.